Teplizumab: The First Treatment to Delay the Progression of Type 1 Diabetes.
Clin Diabetes
; 41(3): 474-476, 2023.
Article
in En
| MEDLINE
| ID: mdl-37456101
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Clin Diabetes
Year:
2023
Type:
Article
Affiliation country:
Morocco